Tag Archives: Biotech

Prove It! Top Line Thoughts on Trends That Will Shape the Industry in 2014

Top Line Thoughts on 2014:  Prove It! Ten days in and the New Year already seems old.  Yet members of our Pharm Exec Editorial Advisory Board are still eager to share their top of line predictions on trends that will shape the industry’s business and reputational assets – forward and backward – over the busy […]
Posted in Biotech, Strategy | Also tagged , , , | Leave a comment

Lessons from Biotech: Tweaking the Imperfections

An increasing number of small biotech companies are being hatched to focus on a single disease or condition. The strategy goes against the diversified portfolio approach most big pharma companies have embraced, and instead puts all the eggs in one basket. Dart Therapeutics—one such company—has taken on Duchenne Muscular Dystrophy (DMD), a disease found in […]
Posted in Biotech, Orphan Drugs, R&D, Strategy | Also tagged , , , , , , | Leave a comment

The Little Orphan That Could: How Alexion is Going Global

Since the initial FDA approval of its flagship orphan drug Soliris in 2007, Alexion Pharmaceuticals has done well for itself as a small biotech firm that focuses on ultra-rare disease. So well in fact, that instead of partnering, the company has taken global expansion into its own hands. Apart from a pipeline that includes asfotase […]
Posted in Biotech, Global, Manufacturing, Market Access, Orphan Drugs, Strategy, Supply Chain | Also tagged , , , , , , , | Leave a comment

Europe's Bioscience 'Oscars': The Contenders

By Peter O’ Donnell. Europe’s closest thing to an Oscar’s ceremony for bioscience will take place in early October. The EuropaBio award for the most innovative European Union biotechnology firm is limited to firms with fewer than 250 staff or turnover or balance sheet of less than about $50 million. The aim is to encourage […]
Posted in Europe, Global, Guest Blog | Also tagged , , | Leave a comment

New York Pharma Forum: Together We Stand

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Posted in Biotech, Events, leadership, People, R&D, Strategy, Technology | Also tagged , , , , , , , , , , | Leave a comment
  • Categories

  • Meta